InvestorsHub Logo
Followers 32
Posts 12599
Boards Moderated 0
Alias Born 08/29/2012

Re: None

Wednesday, 02/16/2022 1:55:50 AM

Wednesday, February 16, 2022 1:55:50 AM

Post# of 401568
***** What nobody is talking about *****

I read the entire board today.

Not one person mentioned anything about the Abuse-Deterrent product entering clinical trials in Q3 or Q4 of this year with a filing in Q1 of 2023.

And here's what's awesome: The ADT product is ALREADY ready to go into clinical trials RIGHT NOW but has been held up due to covid constraints.

Nasrat - "A third one that since I’ve already touched on Oxy ER, we decided to work on running one more clinical trial for ADT product." And the first time we talked to the company, they are ready to run it sometime in Q2 of this year, then it moved to June, and now they are telling us they cannot run this study till September, October. And this is a company we are talking about in the U.S. This is not overseas. This is in the U.S. to run a study like that. The delay is till September, October. Well, when you run a study like that, they run it in September, October, they need a couple of months to finish it. Then, they need about 6 to 8 weeks to finish the reports and do a statistical analysis and compare and contrast and issue us a report. Then, we need a month to file. So, the filing is not going to take place till Q1 of next year, and all because of delays that are resulting really of the supply chain and COVID.



MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News